[On a specific color reaction of primary carbamates].

R. Bourdon,A. Nicaise

1968-09-01

Annales Pharmaceutiques Françaises

Abstract:

What problem does this paper attempt to address?

An increase in the cytosolic concentration of free calcium ions activates the neutrophil NADPH-oxidase provided that the free fatty acid receptor 2 has been allosterically modulated

Simon Lind,Yanling Wu,Martina Sundqvist,Huamei Forsman,Claes Dahlgren

DOI: https://doi.org/10.1016/j.cellsig.2023.110687

Abstract:Signals generated by free fatty acid receptor 2 (FFA2R) can activate the neutrophil NADPH-oxidase without involvement of any orthosteric FFA2R agonist. The initiating signals may be generated by P2Y2R, the receptor for ATP. An FFA2R specific allosteric modulator (PAM; Cmp58) was required for this response and used to investigate the mechanism by which signals generated by ATP/P2Y2R activate an FFA2R dependent process. The P2Y2R induced signal that together with the modulated FFA2R activates neutrophils, was generated downstream of the Gαq containing G protein coupled to P2Y2R. A rise in the cytosolic concentration of ionized calcium ([Ca2+]i) was hypothesized to be the important signal. The hypothesis gained support from the finding that the modulator transferred the neutrophils to a Ca2+sensitive state. The rise in [Ca2+]i induced by the Ca2+ specific ionophore ionomycin, activated the neutrophils provided that an allosteric modulator was bound to FFA2R. The activity of the superoxide generating NADPH-oxidase induced by ionomycin was rapidly terminated and the FFA2Rs could then no longer be activated by the FFA2R agonist propionate or by the signal generated by ATP/P2Y2R. The non-responding state of FFA2R was, however, revoked by a cross-activating allosteric FFA2R modulator. The [Ca2+]i mediated activation of neutrophils with their FFA2Rs allosterically modulated, represent a unique regulatory receptor crosstalk mechanism by which the activation potency of a G protein coupled receptor is controlled by a receptor-crosstalk signaling system operating from the cytosolic side of the plasma membrane.
A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias

Daniele Bolognini,Catherine E Moss,Karolina Nilsson,Annika U Petersson,Iona Donnelly,Eugenia Sergeev,Gabriele M König,Evi Kostenis,Mariola Kurowska-Stolarska,Ashley Miller,Niek Dekker,Andrew B Tobin,Graeme Milligan

DOI: https://doi.org/10.1074/jbc.M116.736157

2016-09-02

Abstract:The short chain fatty acid receptor FFA2 is able to stimulate signaling via both Gi- and Gq/G11-promoted pathways. These pathways are believed to control distinct physiological end points but FFA2 receptor ligands appropriate to test this hypothesis have been lacking. Herein, we characterize AZ1729, a novel FFA2 regulator that acts as a direct allosteric agonist and as a positive allosteric modulator, increasing the activity of the endogenously produced short chain fatty acid propionate in Gi-mediated pathways, but not at those transduced by Gq/G11 Using AZ1729 in combination with direct inhibitors of Gi and Gq/G11 family G proteins demonstrated that although both arms contribute to propionate-mediated regulation of phospho-ERK1/2 MAP kinase signaling in FFA2-expressing 293 cells, the Gq/G11-mediated pathway is predominant. We extend these studies by employing AZ1729 to dissect physiological FFA2 signaling pathways. The capacity of AZ1729 to act at FFA2 receptors to inhibit β-adrenoreceptor agonist-promoted lipolysis in primary mouse adipocytes and to promote chemotaxis of isolated human neutrophils confirmed these as FFA2 processes mediated by Gi signaling, whereas, in concert with blockade by the Gq/G11 inhibitor FR900359, the inability of AZ1729 to mimic or regulate propionate-mediated release of GLP-1 from mouse colonic preparations defined this physiological response as an end point transduced via activation of Gq/G11.
Choledochoduodenal fistula in the setting of Crohn’s disease

S. Knipping,R. Rajpoot,R. Houshyar

DOI: https://doi.org/10.1016/j.radcr.2016.08.018

2016-11-04

Radiology Case Reports

Abstract:
Neutrophil priming that turns natural FFA2R agonists into potent activators of the superoxide generating NADPH-oxidase

Jonas Mårtensson,André Holdfeldt,Martina Sundqvist,Michael Gabl,Terry P Kenakin,Lena Björkman,Huamei Forsman,Claes Dahlgren

DOI: https://doi.org/10.1002/JLB.2A0318-130RR

Abstract:Acetate, an agonist for the free fatty acid receptor 2 (FFA2R/GPR43), triggers an increase in the cytosolic concentration of free Ca2+ in neutrophils without any assembly of the superoxide generating NADPH-oxidase. We show that the phenylacetamide compound 58 (Cmp 58; (S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-phenylthiazol-2-yl)butanamide), lacking a direct activating effect on neutrophils, acts as a positive FFA2R modulator that turns acetate into a potent activating agonist that triggers an assembly of the NADPH-oxidase. The NADPH-oxidase activity could be further increased in neutrophils treated with the pro-inflammatory cytokine TNF-α. Many neutrophil chemoattractant receptors are stored in secretory organelles but no FFA2R mobilization was induced in neutrophils treated with TNF-α. The receptor selectivity was demonstrated through the inhibition of the neutrophil response induced by the combined action of acetate and Cmp 58 by the FFA2R antagonist CATPB. Receptor modulators that positively co-operate with natural FFA2R agonists and prime neutrophils in their response to such agonists, may serve as good tools for further unraveling the physiological functions of FFA2R and its involvement in various diseases. In this study, we show that neutrophils primed with a presumed allosteric FFA2R modulator produce increased amounts of reactive oxygen species when activated by receptor specific agonists.
Agonist-induced activation of human FFA1 receptor signals to extracellular signal-regulated kinase 1 and 2 through Gq- and Gi-coupled signaling cascades

Jing Qian,Yuyang Gu,Chun Wu,Feng Yu,Yuqi Chen,Jingmei Zhu,Xingyi Yao,Chen Bei,Qingqing Zhu

DOI: https://doi.org/10.1186/s11658-017-0043-3

2017-01-01

Cellular & Molecular Biology Letters

Abstract:Background FFA1 is abundantly expressed in the liver, skeletal muscle, monocytes and nervous system, but is particularly abundant in pancreatic β cells. It is widely believed that FFA1 exerts its regulatory roles in a variety of physiological and pathological functions. In response to oleic acid, FFA1 has been shown to induce the activation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) through a mechanism involving EGFR transactivation in a breast cancer cell line. However, the underlying molecular mechanism for ERK1/2 activation mediated by n-6 free fatty acid (LA) in HEK293 cells remains to be further elucidated. Methods A FLAG-FFA1 vector was stably expressed in HEK293 cells. Western blot analysis was applied to investigate the change in LA-induced ERK1/2 phosphorylation change in response to kinase inhibitors. Arrestin-2/3-specific siRNA was used to analyze the effect of arrestin-2/3 knockdown on FFA1-mediated ERK1/2 activation. Results We proved that activation of ERK1/2 by LA was rapid, peaking at 5 min. Further experiments proved that FFA1 couples to a Gq protein and activates PI-PLC, which induces the IP3/Ca 2+ and DAG/PKC signal pathways, both of which are involved in ERK1/2 activation. We also showed that there is no EGFR transactivation, arrestin-2/3 or Gβγ pathway participation in ERK1/2 phosphorylation. Treating cells with PTX abolished ERK1/2 activation at a late time point (≥20 min), indicating a critical role for Gi subunits in FFA1-mediated ERK1/2 activation. Conclusions Our study provides a detailed delineation of the LA-mediated activation of ERK1/2 in HEK293 cells that are stably transfected with human FFA1. We also present evidence of Gi/Gq-induced synergism in the regulation of ERK1/2 phosphorylation. These observations may provide new insights into the pharmacological effects of FFA1 and the physiological functions modulated by FFA1-mediated activation of ERK1/2.
LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2

Yanling Wu,Claes Dahlgren,Huamei Forsman,Martina Sundqvist

DOI: https://doi.org/10.1101/2024.11.12.623248

2024-11-15

Abstract:The endogenous neutrophil chemoattractant leukotriene B4 (LTB4) is a biased signalling agonist that potently increases the intracellular concentration of free calcium ions ([Ca2+]i), but alone is a weak activator of the neutrophil superoxide anion (O2-)-generating NADPH oxidase. However, in this study we show that an allosteric modulator of the free fatty acid 2 receptor (FFA2R) converts LTB4 into a potent NADPH oxidase activating agonist. While an allosteric modulation of FFA2R was required for LTB4 receptor 1 (BLT1R)-mediated activation of the NADPH oxidase, the LTB4-induced increase in [Ca2+]i was not affected by the modulator. Thus, the biased BLT1R signalling pattern was altered in the presence of the allosteric FFA2R modulator, being biased with a preference towards the signals that activate the NADPH oxidase relative to an increase in [Ca2+]i. Both BLT1R and FFA2R belong to the family of G protein-coupled receptors (GPCRs), and our results show that a communication between the activated BLT1R and the allosterically modulated FFA2Rs generates signals that induce NADPH oxidase activity. This is consistent with a previously described receptor transactivation (crosstalk) model whereby the function of one neutrophil GPCR can be regulated by receptor downstream signals generated by another GPCR. Furthermore, the finding that an allosteric FFA2R modulator sensitises not only the response induced by orthosteric FFA2R agonists but also the response induced by LTB4, violates the receptor restriction properties that normally define the selectivity of allosteric GPCR modulators.

Immunology
Evaluation of herbal product use and possible herb-drug interactions in Turkish elderly.

F. P. Turkmenoglu,Y. Kutsal,A. Dolgun,Yagmur Diker,T. Baydar

DOI: https://doi.org/10.1016/j.ctcp.2016.03.004

IF: 3.577

2016-05-01

Complementary Therapies in Clinical Practice

Abstract:
P2X7 receptors exhibit at least three modes of allosteric antagonism

Adam C Oken,Ismayn A Ditter,Nicolas E Lisi,Ipsita Krishnamurthy,Michael H Godsey,Steven E Mansoor

DOI: https://doi.org/10.1126/sciadv.ado5084

2024-10-04

Abstract:P2X receptors are trimeric ion channels activated by adenosine triphosphate (ATP) that contribute to pathophysiological processes ranging from asthma to neuropathic pain and neurodegeneration. A number of small-molecule antagonists have been identified for these important pharmaceutical targets. However, the molecular pharmacology of P2X receptors is poorly understood because of the chemically disparate nature of antagonists and their differential actions on the seven constituent subtypes. Here, we report high-resolution cryo-electron microscopy structures of the homomeric rat P2X7 receptor bound to five previously known small-molecule allosteric antagonists and a sixth antagonist that we identify. Our structural, biophysical, and electrophysiological data define the molecular determinants of allosteric antagonism in this pharmacologically relevant receptor, revealing three distinct classes of antagonists that we call shallow, deep, and starfish. Starfish binders, exemplified by the previously unidentified antagonist methyl blue, represent a unique class of inhibitors with distinct functional properties that could be exploited to develop potent P2X7 ligands with substantial clinical impact.
Healthcare seeking behaviour and delay in diagnosis of leprosy in a low endemic area of China.

Furen Zhang,Shumin Chen,Yiping Sun,Tongsheng Chu

DOI: https://doi.org/10.47276/lr.80.4.416

2009-12-01

Leprosy Review

Abstract:Delay in diagnosis of leprosy can increase the risk of nerve function impairments and promote the transmission of the infection in a community. In order to understand the factors associated with the delays in diagnosis of leprosy, a questionnaire-based interview was conducted to collect information on the delays among 88 newly diagnosed leprosy patients. The results showed that delay was common and associated with the high rate of disability in the study population. The total mean delay was 50.18 months (median 36 months). The mean patient delay was 24-4 months (median 9.5 months) and the mean health service delay was 257 months (median 12 months). Patients with leprosy reported a variety of symptoms/signs at an early stage of the disease, particularly numbness and tingling. Ignorance of the illness was reported to be the main reason for the patient's delay. Health seeking actions ranged from 1 to 50 with a mean of 7.2 after becoming aware of the first symptom/sign. The effectiveness of early diagnosis of leprosy through health promotion in the population needs to be validated and continuous training on leprosy among healthcare providers is needed.
G protein-coupled receptors for energy metabolites as new therapeutic targets

Clara C. Blad,Cong Tang,Stefan Offermanns

DOI: https://doi.org/10.1038/nrd3777

IF: 112.288

2012-07-13

Nature Reviews Drug Discovery

Abstract:Key PointsIn recent years, several G protein-coupled receptors (GPCRs) have been identified that are activated by energy substrates such as fatty acids and sucrose, or by metabolic intermediates such as acetate, lactate or ketone bodies.These carbohydrate or lipid metabolites, by activating specific GPCRs, function in a hormone-like fashion in addition to their role as carriers of energy.Metabolite receptors sense metabolic activity or levels of energy substrates and control the secretion of metabolic hormones or regulate the metabolic activity of particular cells.Synthetic ligands of the heterodimeric sweet receptor taste receptor type 1 member 2 (TAS1R2)–TAS1R3, which is a receptor for mono- and disaccharides, are used as artificial sweeteners but may have additional metabolic functions, as TAS1R2–TAS1R3 appears to be also involved in non-gustatory metabolic functions.The long-chain fatty acid receptors free fatty acid receptor 1 (FFA1; (also known as GPR40) and GPR120 (also known as omega-3 fatty acid receptor 1) mediate beneficial effects by promoting glucose-induced insulin secretion and by inhibiting inflammatory signalling in immune cells, respectively.The short-chain fatty acid receptors FFA2 (also known as GPR43) and FFA3 (also known as GPR41) appear to link the gut microbiota to metabolic and immune functions. Whether these receptors can be exploited therapeutically is currently not clear.Succinate receptor 1 (SUCNR1; also known as GPR91), which is activated by the citric acid cycle intermediate succinate (released by cells following cellular stress or hypoxia), is involved in the regulation of blood pressure, retinal angiogenesis and immune functions.Of the hydroxycarboxylic acid receptors, which are activated by ketone bodies or lactate, hydroxycarboxylic acid receptor 2 (HCA2) — which is also activated by nicotinic acid — in particular is of pharmacological interest as it mediates some anti-dyslipidaemic effects as well as anti-inflammatory effects, which can be used to reduce the progression of atherosclerosis and potentially other diseases.Several of these receptors have been tested as targets for drugs to treat particular metabolic diseases, and various synthetic ligands have been developed in recent years. Agonists of FFA1 and HCA2 are currently being tested in clinical trials.

pharmacology & pharmacy,biotechnology & applied microbiology
The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).

Min Wang,Mingzhang Gao,K. Miller,G. Sledge,G. Hutchins,Q. Zheng

DOI: https://doi.org/10.1016/j.bmcl.2010.11.026

IF: 2.94

Bioorganic & Medicinal Chemistry Letters

Abstract:
β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1

Arturo D Mancini,Gyslaine Bertrand,Kevin Vivot,Éric Carpentier,Caroline Tremblay,Julien Ghislain,Michel Bouvier,Vincent Poitout

DOI: https://doi.org/10.1074/jbc.M115.644450

2015-08-21

Abstract:FFAR1/GPR40 is a seven-transmembrane domain receptor (7TMR) expressed in pancreatic β cells and activated by FFAs. Pharmacological activation of GPR40 is a strategy under consideration to increase insulin secretion in type 2 diabetes. GPR40 is known to signal predominantly via the heterotrimeric G proteins Gq/11. However, 7TMRs can also activate functionally distinct G protein-independent signaling via β-arrestins. Further, G protein- and β-arrestin-based signaling can be differentially modulated by different ligands, thus eliciting ligand-specific responses ("biased agonism"). Whether GPR40 engages β-arrestin-dependent mechanisms and is subject to biased agonism is unknown. Using bioluminescence resonance energy transfer-based biosensors for real-time monitoring of cell signaling in living cells, we detected a ligand-induced GPR40-β-arrestin interaction, with the synthetic GPR40 agonist TAK-875 being more effective than palmitate or oleate in recruiting β-arrestins 1 and 2. Conversely, TAK-875 acted as a partial agonist of Gq/11-dependent GPR40 signaling relative to both FFAs. Pharmacological blockade of Gq activity decreased FFA-induced insulin secretion. In contrast, knockdown or genetic ablation of β-arrestin 2 in an insulin-secreting cell line and mouse pancreatic islets, respectively, uniquely attenuated the insulinotropic activity of TAK-875, thus providing functional validation of the biosensor data. Collectively, these data reveal that in addition to coupling to Gq/11, GPR40 is functionally linked to a β-arrestin 2-mediated insulinotropic signaling axis. These observations expose previously unrecognized complexity for GPR40 signal transduction and may guide the development of biased agonists showing improved clinical profile in type 2 diabetes.
FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils

Michael Gabl,Andre Holdfeldt,Martina Sundqvist,Jalal Lomei,Claes Dahlgren,Huamei Forsman

DOI: https://doi.org/10.1016/j.bcp.2017.08.018

2017-12-01

Abstract:G-protein coupled receptor (GPCR) biased agonism or functional selectivity has become an essential concept in GPCR research over the last years. Receptor-specific biased agonists selectively trigger one signaling pathway over another and induce a restricted/directed functional response. In this study, we aimed to characterize the concept of biased agonism for FPR2, a member of the formyl peptide receptor (FPR) subfamily of GPCRs. We show that the earlier described FPR2-activating pepducin F2Pal10 is a biased FPR2 agonist. The effects of F2Pal10 on neutrophil function differed in several aspects compared to those mediated by WKYMVM, a conventional FPR2-specific peptide agonist. Upon interaction with FPR2 expressed by neutrophils both F2Pal10 and WKYMVM activated the PLC-PIP2-Ca2+ signaling pathway and the superoxide-generating NADPH-oxidase, but only WKYMVM activated the receptor to recruit β-arrestin. The functional consequences linked to a lack of β-arrestin recruitment were further explored, and we demonstrate that FPR2 desensitization occurred independent of β-arrestin. Despite this, reactivation of desensitized receptors achieved through a disruption of the cytoskeleton and through a novel FPR2 cross-talk mechanism with P2Y2R (the ATP receptor) and PAFR (the receptor for PAF) differed between F2Pal10-desensitized and WKYMVM-desensitized neutrophils. Further, the inability to recruit β-arrestin was found to be associated with a reduced rate of receptor internalization and impaired chemotaxis in neutrophils. In summary, we provide experimental evidence of biased agonism for FPR2 and our data disclose critical roles of β-arrestin in neutrophil chemotaxis and reactivation of desensitized receptors.
Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling

Shuo Zhang,Hao Gong,Yunjun Ge,Richard D Ye,Richard D. Ye

DOI: https://doi.org/10.1016/j.phrs.2020.105117

IF: 10.334

2020-11-01

Pharmacological Research

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background and purpose</h3><p>Formyl peptide receptor 2 (FPR2) is a Class A G protein-coupled receptor (GPCR) that interacts with multiple ligands and transduces both proinflammatory and anti-inflammatory signals. These ligands include weak agonists and modulators that are produced during inflammation. The present study investigates how prolonged exposure to FPR2 modulators influence receptor signaling.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Experimental approach</h3><p>Fluorescent biosensors of FPR2 were constructed based on single-molecule fluorescent resonance energy transfer (FRET) and used for measurement of ligand-induced receptor conformational changes. These changes were combined with FPR2-mediated signaling events and used as parameters for the conformational states of FPR2. Ternary complex models were developed to interpret ligand concentration-dependent changes in FPR2 conformational states.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Key results</h3><p>Incubation with Ac<sub>2−26</sub>, an anti-inflammatory ligand of FPR2, decreased FRET intensity at picomolar concentrations. In comparison, WKYMVm (W-pep) and Aβ<sub>42</sub>, both proinflammatory agonists of FPR2, increased FRET intensity. Preincubation with Ac<sub>2−26</sub> at 10 pM diminished W-pep-induced Ca<sup>2+</sup> flux but potentiated W-pep-stimulated β-arrestin2 membrane translocation and p38 MAPK phosphorylation. The opposite effects were observed with 10 pM of Aβ<sub>42</sub>. Neither Ac<sub>2−26</sub> nor Aβ<sub>42</sub> competed for W-pep binding at the picomolar concentrations.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions and implications</h3><p>The results support the presence of two allosteric binding sites on FPR2, each for Ac<sub>2−26</sub> and Aβ<sub>42</sub>, with high and low affinities. Sequential binding of the two allosteric ligands at increasing concentrations induce different conformational changes in FPR2, providing a novel mechanism by which biased allosteric modulators alter receptor conformations and generate pro- and anti-inflammatory signals.</p>

pharmacology & pharmacy
The Covalent Reactivity of Functionalized 5-Hydroxy-butyrolactams is the Basis for Targeting of Fatty Acid Binding Protein 5 (FABP5) by the Neurotrophic Agent MT-21

Esben B. Svenningsen,Rasmus N. Ottosen,Katrine H. Jorgensen,Marija Nisavic,Camilla K. Larsen,Bente K. Hansen,Yong Wang,Kresten Lindorff-Larsen,Thomas Torring,Stephan M. Hacker,Johan Palmfeldt,Thomas B. Poulsen

DOI: https://doi.org/10.1039/d2cb00161f

2022-01-01

Abstract:Covalently acting compounds experience a strong interest within chemical biology both as molecular probes in studies of fundamental biological mechanisms and/or as novel drug candidates. In this context, the identification of new classes of reactive groups is particularly important as these can expose novel reactivity modes and, consequently, expand the ligandable proteome. Here, we investigated the electrophilic reactivity of the 3-acyl-5-hydroxy-1,5-dihydro-2H-pyrrole-2-one (AHPO) scaffold, a heterocyclic motif that is e.g. present in various bioactive natural products. Our investigations were focused on the compound MT-21 - a simplified structural analogue of the natural product epolactaene - which is known to have both neurotrophic activity and ability to trigger apoptotic cell death. We found that the central N-acyl hemiaminal group of MT-21 can function as an electrophilic centre enabling divergent reactivity with both amine- and thiokbased nucleophiles, which furthermore translated to reactivity with proteins in both cell lysates and live cells. We found that in live cells MT-21 strongly engaged the lipid transport protein fatty acid-binding protein 5 (FABP5) by direct binding to a cysteine residue in the bottom of the ligand binding pocket. Through preparation of a series of MT-21 derivatives, we probed the specificity of this interaction which was found to be strongly dependent on subtle structural changes. Our study suggests that MT-21 may be employed as a tool compound in future studies of the biology of FABP5, which remains incompletely understood. Furthermore, our study has also made dear that other natural products containing the AHPO-motif may likewise possess covalent reactivity and that this property may underlie their biological activity.
The ketone body acetoacetate activates human neutrophils through FFAR2

Jonas Mårtensson,Lena Björkman,Simon Lind,Moa Bjerhem Viklund,Linjie Zhang,Saray Gutierrez,Claes Dahlgren,Martina Sundqvist,Xin Xie,Huamei Forsman

DOI: https://doi.org/10.1093/jleuko/qiad035

2023-06-01

Abstract:Neutrophils express many surface receptors that sense environmental changes. One such sensor is FFAR2 (free fatty acid receptor 2), a receptor that detects gut microbiota-derived short-chain fatty acids. As such, FFAR2 has been regarded as a molecular link between metabolism and inflammation. Our recent studies on FFAR2, using its endogenous agonist propionate in combination with allosteric modulators, have identified several novel aspects of FFAR2 regulation. A recent study has also identified the ketone body acetoacetate as an endogenous ligand for mouse FFAR2. Whether human FFAR2 also recognizes acetoacetate and how this recognition modulates human neutrophil functions has not been investigated. In this study, we found that acetoacetate can induce a decrease of cAMP and translocation of β-arrestin in cells overexpressing FFAR2. In addition, we show that similar to propionate, FFAR2-specific allosteric modulators enhance acetoacetate-induced transient rise in cytosolic calcium, production of reactive oxygen species, and cell migration in human neutrophils. In summary, we demonstrate that human neutrophils recognize the ketone body acetoacetate through FFAR2. Thus, our data further highlight the key role of FFAR2 in inflammation and metabolism.
ATP Activates cAMP Production via Multiple Purinergic Receptors in MDCK-D1 Epithelial Cells

Steven R. Post,L. Christian Rump,Alex Zambon,Richard J. Hughes,Mihaela D. Buda,J. Paul Jacobson,Cecilia C. Kao,Paul A. Insel

DOI: https://doi.org/10.1074/jbc.273.36.23093

IF: 5.485

1998-09-01

Journal of Biological Chemistry

Abstract:Extracellular nucleotides regulate function in many cell types via activation of multiple P2-purinergic receptor subtypes. However, it has been difficult to define which individual subtypes mediate responses to the physiological agonist ATP. We report a novel means to determine this by exploiting the differential activation of an autocrine/paracrine signaling pathway. We used Madin-Darby canine kidney epithelial cells (MDCK-D1) and assessed the regulation of cAMP formation by nucleotides. We found that ATP, 2-methylthio-ATP (MT-ATP) and UTP increase cAMP production. The cyclooxygenase inhibitor indomethacin completely inhibited UTP-stimulated, did not inhibit MT-ATP-stimulated, and only partially blocked ATP-stimulated cAMP formation. In parallel studies, ATP and UTP but not MT-ATP stimulated prostaglandin production. By pretreating cells with indomethacin to eliminate the P2Y2/prostaglandin component of cAMP formation, we could assess the indomethacin-insensitive P2 receptor component. Under these conditions, ATP displayed a ten-fold lower potency for stimulation of cAMP formation compared with untreated cells. These data indicate that ATP preferentially activates P2Y2 relative to other P2 receptors in MDCK-D1 cells (P2Y1 and P2Y11, as shown by reverse transcriptase polymerase chain reaction) and that P2Y2 receptor activation is the principal means by which ATP increases cAMP formation in these cells. Blockade of autocrine/paracrine signaling can aid in dissecting the contribution of multiple receptor subtypes activated by an agonist.

biochemistry & molecular biology
Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Zhaotong Cong,Li-Nan Chen,Honglei Ma,Qingtong Zhou,Xinyu Zou,Chenyu Ye,Antao Dai,Qing Liu,Wei Huang,Xianqiang Sun,Xi Wang,Peiyu Xu,Lihua Zhao,Tian Xia,Wenge Zhong,Dehua Yang,H. Eric Xu,Yan Zhang,Ming-Wei Wang

DOI: https://doi.org/10.1038/s41467-021-24058-z

2021-01-01

Abstract:The glucagon-like peptide-1 (GLP-1) receptor is a validated drug target for metabolic disorders. Ago-allosteric modulators are capable of acting both as agonists on their own and as efficacy enhancers of orthosteric ligands. However, the molecular details of ago-allosterism remain elusive. Here, we report three cryo-electron microscopy structures of GLP-1R bound to (i) compound 2 (an ago-allosteric modulator); (ii) compound 2 and GLP-1; and (iii) compound 2 and LY3502970 (a small molecule agonist), all in complex with heterotrimeric G s . The structures reveal that compound 2 is covalently bonded to C347 at the cytoplasmic end of TM6 and triggers its outward movement in cooperation with the ECD whose N terminus penetrates into the GLP-1 binding site. This allows compound 2 to execute positive allosteric modulation through enhancement of both agonist binding and G protein coupling. Our findings offer insights into the structural basis of ago-allosterism at GLP-1R and may aid the design of better therapeutics.
Internalization-Dependent Free Fatty Acid Receptor 2 Signaling Is Essential for Propionate-Induced Anorectic Gut Hormone Release

Natarin Caengprasath,Noemi Gonzalez-Abuin,Maria Shchepinova,Yue Ma,Asuka Inoue,Edward W. Tate,Gary Frost,Aylin C. Hanyaloglu

DOI: https://doi.org/10.1016/j.isci.2020.101449

IF: 5.8

2020-09-01

iScience

Abstract:The ability of propionate, a short-chain fatty acid produced from the fermentation of non-digestible carbohydrates in the colon, to stimulate the release of anorectic gut hormones, such as glucagon like peptide-1 (GLP-1), is an attractive approach to enhance appetite regulation, weight management, and glycemic control. Propionate induces GLP-1 release via its G protein-coupled receptor (GPCR), free fatty acid receptor 2 (FFA2), a GPCR that activates Gαi and Gαq/11. However, how pleiotropic GPCR signaling mechanisms in the gut regulates appetite is poorly understood. Here, we identify propionate-mediated G protein signaling is spatially directed within the cell whereby FFA2 is targeted to very early endosomes. Furthermore, propionate activates a Gαi/p38 signaling pathway, which requires receptor internalization and is essential for propionate-induced GLP-1 release in enteroendocrine cells and colonic crypts. Our study reveals that intestinal metabolites engage membrane trafficking pathways and that receptor internalization could orchestrate complex GPCR pathways within the gut.

multidisciplinary sciences
Purinergic P2Y2 receptors mediate rapid Ca2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells

Abdul Raqeeb,Jianzhong Sheng,Ni Ao,Andrew P. Braun

DOI: https://doi.org/10.1016/j.ceca.2011.02.008

IF: 4.69

2011-01-01

Cell Calcium

Abstract:In blood vessels, stimulation of the vascular endothelium by the Ca2+-mobilizing agonist ATP initiates a number of cellular events that cause relaxation of the adjacent smooth muscle layer. Although vascular endothelial cells are reported to express several subtypes of purinergic P2Y and P2X receptors, the major isoform(s) responsible for the ATP-induced generation of vasorelaxant signals in human endothelium has not been well characterized. To address this issue, ATP-evoked changes in cytosolic Ca2+, membrane potential and acute nitric oxide production were measured in isolated human umbilical vein endothelial cells (HUVECs) and profiled using established P2X and P2Y receptor probes. Whereas selective P2X agonist (i.e. α,β-methyl ATP) and antagonists (i.e. TNP-ATP and PPADS) could neither mimic nor block the observed ATP-evoked cellular responses, the specific P2Y receptor agonist UTP functionally reproduced all the ATP-stimulated effects. Furthermore, both ATP and UTP induced intracellular Ca2+ mobilization with comparable EC50 values (i.e. 1–3μM). Collectively, these functional and pharmacological profiles strongly suggest that ATP acts primarily via a P2Y2 receptor sub-type in human endothelial cells. In support, P2Y2 receptor mRNA and protein were readily detected in isolated HUVECs, and siRNA-mediated knockdown of endogenous P2Y2 receptor protein significantly blunted the cytosolic Ca2+ elevations in response to ATP and UTP, but did not affect the histamine-evoked response. In summary, these results identify the P2Y2 isoform as the major purinergic receptor in human vascular endothelial cells that mediates the cellular actions of ATP linked to vasorelaxation.

[On a specific color reaction of primary carbamates].

An increase in the cytosolic concentration of free calcium ions activates the neutrophil NADPH-oxidase provided that the free fatty acid receptor 2 has been allosterically modulated

A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias

Choledochoduodenal fistula in the setting of Crohn’s disease

Neutrophil priming that turns natural FFA2R agonists into potent activators of the superoxide generating NADPH-oxidase

Agonist-induced activation of human FFA1 receptor signals to extracellular signal-regulated kinase 1 and 2 through Gq- and Gi-coupled signaling cascades

LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2

Evaluation of herbal product use and possible herb-drug interactions in Turkish elderly.

P2X7 receptors exhibit at least three modes of allosteric antagonism

Healthcare seeking behaviour and delay in diagnosis of leprosy in a low endemic area of China.

G protein-coupled receptors for energy metabolites as new therapeutic targets

The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).

β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1

FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils

Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling

The Covalent Reactivity of Functionalized 5-Hydroxy-butyrolactams is the Basis for Targeting of Fatty Acid Binding Protein 5 (FABP5) by the Neurotrophic Agent MT-21

The ketone body acetoacetate activates human neutrophils through FFAR2

ATP Activates cAMP Production via Multiple Purinergic Receptors in MDCK-D1 Epithelial Cells

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Internalization-Dependent Free Fatty Acid Receptor 2 Signaling Is Essential for Propionate-Induced Anorectic Gut Hormone Release

Purinergic P2Y2 receptors mediate rapid Ca2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells